Literature DB >> 18315428

Progression of periodontal disease in a maintenance population of smokers and non-smokers: a 3-year longitudinal study.

Sean Fisher1, Leah Kells, Jean-Pierre Picard, Shirley C Gelskey, David L Singer, Lisa Lix, David A Scott.   

Abstract

BACKGROUND: Cigarette smoking is accepted as an important factor that increases the risk for the initiation and progress of chronic periodontitis. However, the effect of cigarette smoking on the recurrence of disease in patients undergoing regular maintenance therapy is less understood. Therefore, we set out to assess disease progression longitudinally in smoking and non-smoking subjects with chronic periodontitis undergoing periodontal maintenance therapy every 3 to 4 months.
METHODS: A total of 108 subjects undergoing regular maintenance therapy for chronic periodontitis were followed over a 3-year period. Self-reports of smoking status were confirmed by analysis of exhaled carbon monoxide concentrations. Clinical parameters (plaque index [PI], bleeding on probing [BOP], clinical attachment loss [CAL], probing depth [PD], and tooth loss) were recorded at yearly reevaluation visits. The study was carried out in a university hospital setting.
RESULTS: Longitudinal measurements were obtained from 81 (75%) subjects. There were no differences in inflammatory indices at baseline or over time (PI and BOP; both P >0.05) between smokers (N = 16; age: 54 +/- 6 years) and non-smokers (N = 65; age: 59 +/- 14 years). Likewise, there was no difference between the smoking groups with respect to disease progression (measured as changes in prevalence [number] and proportion [percentage] of progressing sites and as mean CAL, PD, and tooth loss; all P >0.05).
CONCLUSION: In this small population, regular maintenance treatment in a cross-section of highly motivated subjects with chronic periodontitis seemed to be equally successful in preventing progressive periodontal tissue destruction in current smokers and current non-smokers.

Entities:  

Mesh:

Year:  2008        PMID: 18315428     DOI: 10.1902/jop.2008.070296

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  7 in total

1.  Fatty acid profiles in smokers with chronic periodontitis.

Authors:  N Buduneli; L Larsson; B Biyikoglu; D E Renaud; J Bagaitkar; D A Scott
Journal:  J Dent Res       Date:  2010-11-01       Impact factor: 6.116

2.  The Effect of Tobacco Smoking on Musculoskeletal Health: A Systematic Review.

Authors:  Ahmad M Al-Bashaireh; Linda G Haddad; Michael Weaver; Debra Lynch Kelly; Xing Chengguo; Saunjoo Yoon
Journal:  J Environ Public Health       Date:  2018-07-11

3.  Vaginal and oral microbes, host genotype and preterm birth.

Authors:  Usha Srinivasan; Dawn Misra; Mary L Marazita; Betsy Foxman
Journal:  Med Hypotheses       Date:  2009-12       Impact factor: 1.538

4.  Characterization and development of SAPP as a specific peptidic inhibitor that targets Porphyromonas gingivalis.

Authors:  Meng-Hsuan Ho; Richard J Lamont; Walter J Chazin; Huiqing Chen; Daphne F Young; Prashant Kumar; Hua Xie
Journal:  Mol Oral Microbiol       Date:  2018-10-30       Impact factor: 3.563

5.  Site-specific treatment outcome in smokers following 12 months of supportive periodontal therapy.

Authors:  Dagmar F Bunaes; Stein Atle Lie; Anne Nordrehaug Åstrøm; Kamal Mustafa; Knut N Leknes
Journal:  J Clin Periodontol       Date:  2016-09-30       Impact factor: 8.728

6.  A novel peptidic inhibitor derived from Streptococcus cristatus ArcA attenuates virulence potential of Porphyromonas gingivalis.

Authors:  Meng-Hsuan Ho; Richard J Lamont; Hua Xie
Journal:  Sci Rep       Date:  2017-11-24       Impact factor: 4.379

7.  Surgical and Non-Surgical Procedures Associated with Recurrence of Periodontitis in Periodontal Maintenance Therapy: 5-Year Prospective Study.

Authors:  Fernando Oliveira Costa; Luís Otávio Miranda Cota; José Roberto Cortelli; Sheila Cavalca Cortelli; Renata Magalhães Cyrino; Eugênio José Pereira Lages; Ana Paula Lima Oliveira
Journal:  PLoS One       Date:  2015-10-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.